Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Feb 2;7(4):848-856.
doi: 10.1016/j.ekir.2022.01.1063. eCollection 2022 Apr.

Retinal Drusen Are More Common and Larger in Systemic Lupus Erythematosus With Renal Impairment

Affiliations

Retinal Drusen Are More Common and Larger in Systemic Lupus Erythematosus With Renal Impairment

Ye Ji Ham et al. Kidney Int Rep. .

Abstract

Introduction: Complement has been implicated in systemic lupus erythematosus (SLE) pathogenesis on the basis of the associations with inherited complement defects and genome-wide association study risk alleles, glomerular deposits, reduced serum levels, and occasional reports of retinal drusen. This study examined drusen in SLE and their clinical significance.

Methods: This cross-sectional observational study compared individuals with SLE recruited from renal and rheumatology clinics with hospital controls. Participants were reviewed for clinical features and underwent imaging with a nonmydriatic retinal camera. Deidentified images were examined by 2 trained graders for drusen number and size using a grid overlay.

Results: The cohort with SLE (n = 65) comprised 55 women (85%) and 10 men (15%) with a median age of 47 years (interquartile range 35-59), where 23 (35%) were of southern European or Asian ancestry, and 32 (49%) had biopsy-proven lupus nephritis. Individuals with SLE had higher mean drusen numbers than controls (27 ± 60, 3 ± 9, respectively, P = 0.001), more drusen counts ≥10 (31, 48% and 3, 5%, respectively, P < 0.001), and more medium-large drusen (14, 22% and 3, 5%, respectively, P < 0.001). In SLE, mean drusen counts were higher, and drusen were larger, with an estimated glomerular filtration rate (eGFR) <90 ml/min per 1.73 m2 (P = 0.02, P = 0.02, respectively) or class IV nephritis (P = 0.03, P = 0.02).

Conclusion: Drusen composition resembles that of glomerular immune deposits. CFH controls complement activation in the extracellular matrix and CFH risk variants are shared by drusen in macular degeneration and by SLE. CFH represents a possible treatment target for SLE especially with renal impairment.

Keywords: SLE; complement; drusen; immune complexes; impaired kidney function; lupus nephritis.

PubMed Disclaimer

Figures

None
Graphical abstract
Figure 1
Figure 1
Drusen grading schemes for the macula, according to the modified ETDRS Grid. ETDRS, Early Treatment of Diabetic Retinopathy Study.
Figure 2
Figure 2
Retinal images demonstrating drusen in SLE. (a) An example of numerous retinal drusen in an individual with SLE; (b) black and white image of a. demonstrating the drusen more clearly; (c) drusen at the temporal macular in an individual with class IV nephritis; (d) black and white image of c. demonstrating the drusen more clearly; (e) retinal pigment epithelial atrophy and depigmentation (arrow) in an individual with SLE; and (f) enlarged view of the retinal atrophy. SLE, systemic lupus erythematosus.

Similar articles

Cited by

References

    1. Tesar V., Hruskova Z. Lupus nephritis: a different disease in European patients? Kidney Dis (Basel) 2015;1:110–118. doi: 10.1159/000438844. - DOI - PMC - PubMed
    1. Aringer M., Costenbader K., Daikh D., et al. 2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus. Arthritis Rheumatol. 2019;71:1400–1412. doi: 10.1002/art.40930. - DOI - PMC - PubMed
    1. Mohan C., Putterman C. Genetics and pathogenesis of systemic lupus erythematosus and lupus nephritis. Nat Rev Nephrol. 2015;11:329–341. doi: 10.1038/nrneph.2015.33. - DOI - PubMed
    1. Houssiau F.A. Toward better treatment for lupus nephritis. N Engl J Med. 2011;365:1929–1930. doi: 10.1056/NEJMe1111089. - DOI - PubMed
    1. Yu F., Haas M., Glassock R., Zhao M.H. Redefining lupus nephritis: clinical implications of pathophysiologic subtypes. Nat Rev Nephrol. 2017;13:483–495. doi: 10.1038/nrneph.2017.85. - DOI - PubMed